MEETINGS - Annual BIA European CEO (Chief Executive Officer) investor conference (UK) November 2001:
This article was originally published in Clinica
The 2nd Annual BIA European CEO investor conference will take place on November 27-28 2001 at the Shaw Park Plaza, London, UK. Its aim is to present an independent overview of the biotech sector. Designed for CEOs, biotechnology-focused investors and industry leaders, the event will feature CEO roundtable discussions, investor panels and European company presentations. Further details on tel: +44 (0)20 7565 7190; fax: +44 (0)20 7565 7190; email: firstname.lastname@example.org www.biaceo.com
You may also be interested in...
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.